Consolidated Non-Financial Information Statement and Sustainability Information

Report overview

The report presents Pharma Mar's 2025 sustainability performance under ESRS, including SBTi-validated emissions targets, detailed energy and GHG inventories, and a double materiality assessment. It reports 12,402 MWh of total energy consumption and documents 12 marine biodiversity expeditions in three countries. Workforce, water, waste, governance, taxonomy, and business-conduct disclosures are also provided, with the statement and sustainability reporting subject to KPMG limited assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Assurance

Provider
Level
Standard
Scope
Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women on the board
Women in management
Workplace fatalities
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services